Average Co-Inventor Count = 5.44
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (20 from 2,076 patents)
2. Astex Therapeutics Limited (2 from 123 patents)
22 patents:
1. 10045982 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
2. 9636341 - Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
3. 9598396 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
4. 9533979 - Amino-derivatives as novel inhibitors of histone deacetylase
5. 9309242 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
6. 9150543 - Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
7. 9150540 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
8. 8916554 - Amino-derivatives as novel inhibitors of histone deacetylase
9. 8889866 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
10. 8778966 - Quinolinone derivatives as PARP and tank inhibitors
11. 8592441 - Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12. 8524711 - Amino-derivatives as novel inhibitors of histone deacetylase
13. 8524728 - Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
14. 8343988 - Inhibitors of histone deacetylase
15. 8299256 - Quinolinone derivatives as PARP and TANK inhibitors